Equity Rights Offering
Company: Core Scientific
The claim, verbatim
Equity rights offering of $55 million in common shares of reorganized company priced at 30% discount to $1.5 billion enterprise value
Source (primary)
Core Scientific 8-K filed 2023-11-22 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “the Company is conducting an equity rights offering (the 'Equity Rights Offering') of common shares of the reorganized Company (the 'ERO Shares') in an aggregate amount of $55 million (the 'Rights Offering Amount'), at a price per share resulting from a 30% discount to the Plan Equity Value (as defined in the Plan), based on a total enterprise value $1.5 billion”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific 8-K filed 2023-11-22
Quote: “the Company is conducting an equity rights offering (the 'Equity Rights Offering') of common shares of the reorganized Company (the 'ERO Shares') in an aggregate amount of $55 million (the 'Rights Offering Amount'), at a price per share resulting from a 30% discount to the Plan Equity Value (as defined in the Plan), based on a total enterprise value $1.5 billion”